baber/WOPTO huggingface dataset:
Patent NZ-245612-A (NZ)
Title: Substituted thiazolidine derivatives; pharmaceutical compositions and preparatory processes
Inventor: YOSHIOKA TAKAO
IPC: A61P3/08
Filed: 1992-12-23
Abstract: Compounds of formula (I): <CHEM> (in which: R<1> is alkyl; R<2> and R<3> are each alkyl or alkoxy, or R<2> and R<3> together form an optionally substituted benzene ring, and, when R<2> and R<3> together form said benzene ring, R<1> is hydrogen, halogen or alkyl; R<4> and R<5> are hydrogen, or R<4> and R<5> together represent a single carbon-carbon bond; Y<1> and Y<2> are each hydrogen, alkyl, acyl, or optionally substituted benzoyl, naphthoyl, pyridine-carbonyl or quinolinecarbonyl; W is a single bond or alkylene; and Z is hydrogen or a cation) have valuable therapeutic and prophylactic activities, including anti-diabetic activities.
Patent NZ-266724-A (NZ)
Title: Method for detecting target nucleic acid and kit therefor; using primers with at least 5 consecutive nucleotides matching or blocking polymerase composition
Inventor: WANG CHANG-NING J
IPC: C07H21/04
Filed: 1994-05-23
Abstract: A method for detecting a target nucleic acid, which method includes the steps (i) amplifying the target nucleic acid to obtain an amplification product using a polymerase, a first primer with or without a segment noncontiguous to a first priming sequence, and a second primer with or without a segment noncontiguous to a second priming sequence in the presence of an oligonucleotide which is incapable of acting as a primer for the polymerase, wherein the oligonucleotide has at least 5 consecutive nucleotides fully complementary to at least 5 consecutive nucleotides of the first primer; and (ii) detecting the presence of the target nucleic acid by monitoring amplification thereof. In particular, the figure illustrates the method wherein the primer contains a segment noncontiguous to its priming sequence.
Patent NZ-279030-A (NZ)
Title: 2'-deoxy-2'-(fluoromethylene)cytidine
Inventor: DONALDSON RICHARD EUGENE
IPC: C07D405/04
Filed: 1994-12-13
Abstract: The present invention relates to the novel monohydrate or (E)-2'-deoxy-2'-(fluoromethylene)cytidine useful as a ribonucleotide reductase inhibitor in the treatment of patients afflicted with neoplastic or viral disease states.
Patent NZ-303415-A (NZ)
Title: Di-n-substituted piperazine or 1,4 di-substituted piperadine derivatives, preparation and pharmaceutical compositions thereof
Inventor: LOWE DEREK
IPC: C07D409/14
Filed: 1996-02-16
Abstract: Di-N-substituted piperazine or 1,4 di-substituted piperadine compounds in accordance with formula I (including all isomers, salts, esters, and solvates) wherein R, R1, R2, R3, R4, R21, R27, R28, X, Y, and Z are as defined herein are muscarinic antagonists useful for treating cognitive disorders such as Alzheimer's disease. Pharmaceutical compositions and methods of preparation are also disclosed. Also disclosed are synergistic combinations of compounds of the above formula or other compounds capable of enhancing acetylcholine release with acetylcholinesterase inhibitors.
Patent NZ-309499-A (NZ)
Title: Styryl benzimidazole derivatives useful as inhibitors of smooth muscle cell proliferation
Inventor: CHAI SIE-YEARL
IPC: A61K31/4184
Filed: 1996-06-03
Abstract: The benzimidazole derivative has the formula I or II wherein: R is furyl, pyridyl or optionally substituted alkoxy substituted phenyl; R1 and R2 are independently H, halogen, alkoxy, nitro, carboxyl, alkoxycarbonyl or aryloxycarbonyl; R3 is H or benzyl substituted with alkoxycarbonyl; R4 and R5 are independently H or methyl provided that: a) in formula I R1 to R3 are not all H; b) in formula I when R is phenyl or  pyridyl one of R1 and R2 is not n nitro when the other is H and c) the compound of formula I is not 2-[2-(3,4-dimethoxyphenyl)vinyl]-5-nitro-1H-benzimidazole or 2-[2-(4-methoxyphenylvinyl]-5-nitro-1H-benzimidazole. A pharmaceutical composition thereof useful for treating disease or conditions related to smooth muscle cell proliferation.
Patent NZ-309548-A (NZ)
Title: Use of phosphate-binding polymers for oral administration
Inventor: HOLMES-FARLEY STEPHEN RANDALL
IPC: C08F8/00
Filed: 1996-06-03
Abstract: The use of phosphate-binding polymers for removing phosphate from the gastrointestinal tract is disclosed. The polymers are orally administered, and are useful for the treatment of hyperphosphatemia.
Patent NZ-331826-A (NZ)
Title: A method of establishing a communication call over a network using the internet
Inventor: WIENER VICTOR
IPC: H04M7/12
Filed: 1997-03-13
Abstract: The application is for a method, system, interface and server for establishing a communications call by selecting a B party (6) using an interactive device (16) connected to a public network (10, 12), sending called address data for the B party (6) and calling address data for an A party (4) to a communications platform (18) of the public network (10, 12), and establishing a call between the A and B parties (4, 6) over the public network (10, 12) using the communications platform (18) and the called and calling address data.  The called address data can be accessed from the public network, and may reside on a server of a messaging network, such as the Internet.
Patent NZ-332188-A (NZ)
Title: Granulocyte colony stimulating factor (G-CSF) hybrid molecules and 3D structure
Inventor: OSSLUND TIMOTHY D
IPC: G06F19/00
Filed: 1994-01-25
Abstract: A G-CSF hybrid molecule comprising a G-CSF analog moiety and a biologically active protein moiety characterised by: a) having amino acids 2-175 of Sequence ID No 2; b) having an overall three-dimensional conformation shown in figure 4 where i) an anti-parallel 4-alpha helical bundle with a left hand twist; ii) an overall dimension of 45Å x 30Å x 24Å iii) a helix crossing angles ranging from -167.5 to 159.4o c) having a biologically active protein attached to an amino acid selected from among amino acids 119-145 of the CD loop of Sequence ID No 2.
Patent NZ-503762-A (NZ)
Title: Capturing illuminated image by document scanning camera for verification of scanning system performance
Inventor: COSSETTE MARIO A
IPC: H04N1/00
Filed: 2000-05-04
Abstract: An image-based document processing system includes an imaging camera 52 (CCD line camera) having an image acquisition rate to capture images of documents 30 (cheques) being transported along the transport path 11.  A selective illumination array 64 is disposed along the transport path and generates selective illumination data that is synchronized to the acquisition rate of the imaging camera.  A controller 56 controls the capture of images of the document and the selective illumination array.
Patent NZ-508648-A (NZ)
Title: Method for producing isoxazoline-3-yl-acyl benzene
Inventor: GEBHARDT JOACHIM
IPC: C07D/
Filed: 1999-05-04
Abstract: A process for preparing isoxazol-3-ylacylbenzenes of formula (I) is disclosed, wherein where the substituents are as defined below: R1 is hydrogen, C1-C6-alkyl; R2 is C1-C6-alkyl; R3, R4, R5 are hydrogen, C1-C6-alkyl, or R4 and R5 together form a bond; R6 is a heterocyclic ring; and n is 0, 1 or 2. Intermediates (for example an intermediate compound of formula (VI)) for preparing isoxazol-3-ylacylbenzenes and processes for preparing the intermediates are also disclosed. The intermediate compounds further involve are halogenation, thiomythelation, oxidation and acylation to yield isoxazol-3- ylacylbenzenes of formula (I).
Patent NZ-508890-A (NZ)
Title: A mutant human hepatitis B viral strain and used thereof
Inventor: OON CHONG JIN
IPC: G01N33/576
Filed: 1998-06-19
Abstract: An isolated strain of Hepatitis B virus designated Human Hepatitis B Virus Surface Antigen-'S'-133 Oon Strain (Methionine to Threonine) and deposited under Accession Nos P97121504, P97121505 and P97121506 with the European Collection of Cell Culture on 15th December 1997.
Patent NZ-520836-A (NZ)
Title: Pyrano[2,3-c]imidazo[-1,2-a]pyridine derivatives for the treatment of gastrointestinal disorders
Inventor: SENN-BILFINGER JORG
IPC: C07D491/147
Filed: 2001-03-28
Abstract: Pyrano[2,3-c]imidazo[-1,2-a]pyridine derivative compounds of formula (1) that are suitable for the prevention and treatment of gastrointestinal diseases are disclosed, wherein the substituents are as defined in the specification.
Patent NZ-521636-A (NZ)
Title: Systems and methods for controlling television distribution bandwidth and for utilizing real-time statistical wagering data
Inventor: GARAHI MASOOD
IPC: H04N7/173
Filed: 2001-03-16
Abstract: A system for distributing video feeds to the equipment of multiple users, each with a set-top box and television, a personal computer or handheld computing device or other user computer equipment, or a cellular telephone with a display or other user telephone equipment. The video feeds may be distributed to the user equipment using feed distribution equipment and its demand may be monitored with its distribution changed accordingly. The user may be provided with opportunities to place wagers using the equipment and statistics related to the wagers may be gathered in real time and various actions taken based on these.
Patent NZ-522293-A (NZ)
Title: Method for uniform distribution of metal powders of different densities in a mixture
Inventor: BEAL HAROLD F
IPC: F42B12/74
Filed: 2001-04-19
Abstract: A method is disclosed by which the distribution of  the particulates  of a plurality of metal powders  (10,12),  the metals  of each powder being of different densities, may  be uniformly disbursed within a dry mixture of the powders  and by  which  this uniform dispersion of the different  density powders can be sustained through subsequent handling  and/or storage  of  the mixture. In accordance with one  aspect  of the present invention, a quantity of each of a plurality  of metal  powders  is admixed with a dry stabilizing  non-metal powder (14). One particularly useful non-metal powder  is  a micronized polymer, preferably micronized polyethylene.
Patent NZ-522628-A (NZ)
Title: Flower arranging apparatus
Inventor: WRIGHT DALE KATHLEEN
IPC: A47G7/02
Filed: 2001-04-19
Abstract: Flower arranging apparatus (10) for arranging a bunch of flowers (30) including a sheet of substantially flexible material (11); a plurality of penetrations (14) through the sheet (11) adapted to receive there through elongate items (21) of the bunch to flowers (30) to be arranged; gripping means (18) operatively associated with each penetration (14) whereby one or more elongate items (21) may be passed through one or more of the penetrations (14) and gripped thereby with a predetermined force, the penetrations (14) being reinforced against failure of the flexible material about the penetration (14) by a thickening (42) of the flexible material and/or one or more round apertures (49) operatively associated with each penetration (14).
Patent NZ-524895-A (NZ)
Title: Lactobacillus paracasei P1-3, DSM 13433 when used as an adjunct in the manufacture of low fat cheese reduces the bitter flavour associated with low-fat cheeses
Inventor: ANTONSSON MARTIN
IPC: A23C19/032
Filed: 2001-10-03
Abstract: Described is a new strain Lactobacillus paracasei P1-3, DSM 13433, or a variant thereof, which can be used as an adjunct in the manufacture of cheese. The invention also refers to cheese containing the strain, especially low-fat cheese, having a reduced bitterness.
Patent NZ-526062-A (NZ)
Title: Aroma product resulting from recovery process
Inventor: MANDRALIS ZENON IOANNIS
IPC: A23F5/48
Filed: 1999-02-04
Abstract: Disclosed is an aromatized soluble coffee powder that includes at least 0.60 equivalent ìg/g furans and at least 0.40 equivalent ìg/g diketones. The coffee powder may be prepared by a process comprising: (a) providing a slurry of coffee grounds in a aqueous liquid, (b) stripping aroma components from the slurry using gas in a substantially counter-current manner for providing an aromatized gas containing aroma components, (c) collecting the aroma components from the aromatized gas, (d) extracting soluble coffee solids from coffee grounds and concentrating the extracted soluble coffee solid for providing a concentrated coffee extract, (e) combining the concentrated coffee extract and the collected aroma components for providing an aromatized extract, (f) drying the aromatized extract for providing the aromatized coffee powder. (62) Divided out of 506838
Patent NZ-531557-A (NZ)
Title: Shot control hosel
Inventor: BOONE DAVID D
Filed: 2003-04-04
Abstract: A shot control hosel (10) is disclosed for customizing golf clubs. The disclosed embodiments provide a set of hosels (10c, 10d, 10e), each hosel having a conical body (12). The body has a central axis, a top portion (16) and a bottom portion (14). A cylindrical opening (23) extends from the top portion to the bottom portion and is adapted to accommodate a golf club shaft (34). A flange (21) may be provided on the body and may be adapted to engage a notch (32) within a bore of a golf club head. A resilient barb (18) on the smaller of the top portion and the bottom portion is provided to secure the hosel within the bore.
Patent NZ-532214-A (NZ)
Title: Protective relay capable of protection applications without protection settings
Inventor: SCHWEITZER EDMUND O
IPC: H02H7/30
Filed: 2004-04-07
Abstract: A current differential protective relay without adjustable operational settings for use in protecting a selected line portion of a power system comprises: at least one phase current differential element, having a first predetermined, fixed threshold value, responsive to phase currents from the power system at local locations of protective relay and to phase currents from a remote relay on the selected line portion, to detect three-phase faults on the line portion and for providing a first output signal then the predetermined threshold is exceeded by three-phase current, A negative sequence current differential element or two-phase current differential elements, having a second predetermined, fixed threshold value, responsive to local phase currents and remote phase currents to detect phase-to-phase faults and phase-to-phase-to-ground faults and for providing a second output signal when the second predetermined threshold is exceeded, wherein the two phase current differential elements include the one phase current differential element for detecting three-phase faults, or two additional phase current differential elements, and A negative sequence current differential element or a zero sequence differentia element, having a third predetermined, fixed threshold value, responsive to the local phase currents and remote phase currents to detect individual phase-to-ground faults and providing a third output signal when the third predetermined threshold is exceeded, wherein if the negative sequence current differential element is used, it is either the negative sequence current differential element used for detecting phase-to-phase and phase -to-phase-to-ground faults or a second negative sequence current differential element , wherein none of the current differential elements include adjustable operational settings.
Patent NZ-535162-A (NZ)
Title: A utility belt with a removable tool insert placed in a holster coupled to the belt
Inventor: LOGAN STEPHEN ERIC
Filed: 2004-09-08
Abstract: A utility belt for use in supporting and retaining cooking utensils and cooking accessories has a waistband (11). At least one holster (16) is coupled to the waistband (11). A removable tool insert (22) is located in the holster (16). The tool insert (22) is configured to receive a part of a cooking implement or tool (23, 25) to retain the cooking implement or tool. In a preferred form, there are a plurality of holsters (16) at least some of which have a removal insert (22). The holster (16) can be attached to an upper pocket (14). The insert (22) has an uppermost mouth opening (28) into an otherwise enclosed space, which is configured to receive the part of the cooking tool or implement (23, 25) and in a preferred form to receive same in an interference fit.
Patent NZ-536295-A (NZ)
Title: Use of the metabolite valeryl 4-hydroxy valsartan for inhibiting platelet aggregation
Inventor: MALININ ALEX
IPC: A61K31/4184
Filed: 2003-05-13
Abstract: Disclosed herein is a use of the metabolite valeryl 4-hydroxy valsartan or a pharmaceutically acceptable salt thereof for the manufacture of a medicament for inhibiting platelet aggregation, optionally in the presence of a pharmaceutically acceptable carrier. Conditions to be treated by inhibition of platelet aggregation include acute myocardial infarction, ischemic stroke, angina pectoris, acute coronary syndromes, TIA (transient ischemic attacks, or acute cerebrovascular syndromes), heart failure, chest pain of ischemic etiology, syndrome X, thromboembolism, pulmonary hypertension, diabetes mellitus, peripheral vascular disease, deep vein thrombosis, arterial thrombosis of any vessel, catheter thrombotic occlusion or reocclusion.
Patent NZ-539353-A (NZ)
Title: Controlled release preparation
Inventor: AKIYAMA YOHKO
IPC: A61K31/4439
Filed: 2003-10-15
Abstract: Disclosed is a capsule comprising: (i) a tablet, granule or fine granule in which the release of active ingredient is controlled comprising a core particle containing an imidazole compound represented by the formula (I') as defined in the specification, and a pH-dependently soluble release-controlled coating-layer which comprises one kind of polymeric substance or a mixture of two or more kinds of polymeric substances having different release properties, said substance being soluble in the pH range of 6.0 to 7.5; and (ii) a tablet, granule or fine granule comprising a core particle containing the active ingredient as defined above and an enteric coat which is dissolved in the pH range of no less than 5.0, nor more than 6.0.
Patent NZ-540343-A (NZ)
Title: Compositions and methods for the diagnosis and treatment of tumor
Inventor: ASHKENAZI AVI J
IPC: C12Q1/68
Filed: 2003-11-13
Abstract: Provided is a method of diagnosing the presence of a tumor in a mammal, the method comprising (i) determining the level of expression ofa gene encoding a TAT 408 polypeptide with a specified sequence in a test sample of tissue cells obtained from the mammal, and (ii) comparing the level of expression of (i) with the level of expression of said nucleic acid in a control sample; wherein a significantly higher level of expression of the gene encoding the protein in the test sample, as compared to the control sample, is indicative of the presence of tumor.
Patent NZ-541710-A (NZ)
Title: Gene expression of polypeptides comprising the stress-protective vacuolar pyrophosphatase in plants
Inventor: SMITH-ESPINOZA CLAUDIA JEANNET
Filed: 2005-08-09
Abstract: Disclosed are stress-responsiveness promoters suitable for directing gene expression in plant cells or plants. Also disclosed is the method of producing a plant cell or plant with altered expression of at least one polynucleotide sequence of interest.
Patent NZ-543377-A (NZ)
Title: Process of making press molded materials using heat activated tertiary amine urethane catalysts
Inventor: MORIARTY CHRISTOPHER J
IPC: C08K5/34
Filed: 2004-05-03
Abstract: A process for the manufacture of a press molded material is disclosed, which comprises applying diisocyanate, polyol (optionally), and catalyst to a wood material, wherein the catalyst is a tertiary amine-carboxylic acid salt that is blocked at room temperature and becomes unblocked at an elevated temperature, and heating the resulting mixture of diisocyanate, polyol, catalyst and wood material to a temperature effective to unblock the salt to produce unblocked tertiary amine. The press molded material can be an orientated strand board (OSB).
Patent NZ-545921-A (NZ)
Title: Delayed released dosage forms
Inventor: BAICHWAL ANAND R
IPC: A61K9/24
Filed: 2004-09-17
Abstract: Disclosed is a delayed release oral solid dosage form comprising: a core comprising a therapeutically effective amount of a drug, a surfactant, and a pharmaceutically acceptable diluent; and a delayed release material compression coated onto the surface of said core, said delayed release material comprising a mixture of xanthan gum and locust bean gum; said dosage form providing a delay in the release of the drug from about 2 to about 18 hours after administration, and said surfactant facilitates complete release of the drug from the dosage form in less than 4 hours after initial release.
Patent NZ-546823-A (NZ)
Title: Inkjet ink composition exhibiting low gloss
Inventor: TILLER THOMAS
IPC: C09D11/00
Filed: 2004-11-04
Abstract: Disclosed is the use of at least one hydrocarbon compound having a carbon chain of two to six carbon atoms carrying two or three hydroxyl groups in an inkjet printing ink composition as a non-particulate matting compound for adapting the gloss of a printed marking to the gloss of a substrate carrying the marking, such that the marking is not discernible by an unaided eye.
Patent NZ-546959-A (NZ)
Title: Improved cleaning method for a porous membrane filtration module
Inventor: JOHNSON WARREN THOMAS
IPC: B01D65/08
Filed: 2004-11-12
Abstract: An aeration/backwash device (16) for use with a porous membrane filtration module (5) including one or more membranes (6) extending longitudinally between vertically spaced upper (7) and lower headers (8) into which the ends of the membranes are potted, is disclosed. The membranes (6) have a permeable wall which, in use, is subjected to a filtration operation wherein feed containing contaminant matter is applied to one side of the membrane wall and filtrate is withdrawn from the other side of the membrane wall. The aeration/backwash device (16) adapted to at least partially surround a portion of the membrane module (5) and includes a communication chamber (17) having spaced through-openings (18, 19) in fluid communication with the chamber (17) and the membrane module (5). In use, gas is supplied to the chamber (17) and communicated to the membrane module (5) through the through-openings (18, 19) to aerate the membranes within the membrane module and liquid backwash is withdrawn from and/or fed into the membrane module (5) through the through openings into the chamber (17).
Patent NZ-548796-A (NZ)
Title: N-substituted trycyclic 3-aminopyrazoles as PDFG receptor inhibitors
Inventor: HO CHIH YUNG
IPC: A61F2/82
Filed: 2003-05-13
Abstract: Disclosed are N-substituted tricyclic 3-aminopyrazole compounds of formula (I) and the use of such compounds to treat cell proliferative disorders, such as tumours, restenosis, rheumatoid arthritis, diabetic retinopathy and the like. More particularly, the compounds are inhibitors of the PDGF receptor tyrosine kinase.
Patent NZ-549040-A (NZ)
Title: Use for interleukin-33 (IL33) and the IL-33 receptor complex
Inventor: SCHMITZ JOCHEN
IPC: A61K48/00
Filed: 2004-11-29
Abstract: Disclosed is the use of an agonist or antagonist of IL-33 for the manufacture of a medicament for modulating an immune disorder or condition, wherein: a) the agonist of IL-33 is IL-33 or a nucleic acid encoding IL-33; and b) the antagonist of IL-33 is an antibody that specifically binds to IL-33 (or antigen binding fragment thereof), an siRNA to IL-33, or antisense nucleic acid to IL-33.
Patent NZ-550110-A (NZ)
Title: Compositions and methods comprising an EGFL7 antagonist for modulating vascular development
Inventor: FILVAROFF ELLEN
IPC: A61K31/7088
Filed: 2005-04-14
Abstract: Disclosed is a use of an EGFL7 antagonist capable of interfering with EGFL7-induced endothelial cell migration in the manufacture of a medicament for reducing or inhibiting angiogenesis in a subject having a pathological condition associated with angiogenesis, wherein the EGFL7 antagonist is an antibody, an antisense oligonucleotide or a ribozyme.